Bone Morphogenetic Protein 2-Coated Porous Poly-L-lactic Acid Scaffolds: Release Kinetics and Induction of Pluripotent C3H10T1/2 Cells
- 1 March 1998
- journal article
- research article
- Published by Mary Ann Liebert Inc in Tissue Engineering
- Vol. 4 (1) , 35-51
- https://doi.org/10.1089/ten.1998.4.35
Abstract
Induction of a pluripotent C3H10T1/2 (Tl/2) stem cell line down the osteoblastic lineage was demonstrated in vitro using a three-dimensional, porous poly-L-lactic acid (PLLA) scaffold containing bone morphogenetic protein 2 (rhBMP-2). PLLA sponges (100 kDa) were fabricated using a solvent casting/particulate leaching method. C3H10T1/2 cells (5 × 105) and BMP (2.2–6.6 µg) were suspended in collagen I gel and seeded on the scaffold, or rhBMP-2 was precoated on the scaffold and followed by cell seeding. rhBMP-2 release from cell-free rhBMP-2-coated scaffolds, measured directly by enzyme-linked immunosorbant assay (ELISA) and indirectly by alkaline phosphatase assay of Tl/2 cells treated with rhBMP-2-conditioned media, showed release from scaffolds for up to 14 days, with no difference between suspension and precoat groups. Cell-seeded samples were evaluated at 7, 14, and 28 days by histology and scanning electron microscopy, which revealed morphological differences between rhBMP-2 and non-BMP groups. Cells remained viable throughout the study, and osteocalcin immunofluorescence, used to test for osteoinduction, showed a time- and dose-dependent osteocalcin expression in all rhBMP-2 groups, with no staining observed in non-BMP controls. In summary, a single initial dose of rhBMP-2 within a three-dimensional PLLA scaffold was sufficient to induce pluripotent Tl/2 cells to differentiate into the osteoblastic lineage. The availability of tissue-enginered substitutes would simplify bone-grafting procedures.Keywords
This publication has 31 references indexed in Scilit:
- The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2Published by Elsevier ,2005
- Maxillary Alveolar Cleft Repair in Dogs Using Recombinant Human Bone Morphogenetic Protein-2 and a Polymer CarrierPlastic and Reconstructive Surgery, 1996
- Fibroblast seeding and culture in biodegradable porous substratesJournal of Applied Biomaterials, 1995
- Recombinant human bone morphogenetic protein‐2 is superior to demineralized bone matrix in repairing craniotomy defects in ratsJournal of Biomedical Materials Research, 1994
- Bone Defect Repair with Tissue-Engineered CartilagePlastic and Reconstructive Surgery, 1994
- Healing of large segmental defects in rat femurs is aided by RhBMP‐2 in PLGA matrixJournal of Biomedical Materials Research, 1994
- A study on the in vitro degradation of poly(lactic acid)Journal of Biomaterials Science, Polymer Edition, 1994
- Resorbable synthetic polymers s replacements for bone graftClinical Materials, 1994
- Bone Morphogenetic Protein-2 Causes Commitment and Differentiation in C3Hl0T1/2 and 3T3 CellsGrowth Factors, 1993
- Bone morphogenetic protein-2b stimulation of growth and osteogenic phenotypes in rat osteoblast-like cells: Comparison with TGF-β1Journal of Bone and Mineral Research, 1991